Executive Order Directs CDC to Reduce Number of Recommended Childhood Vaccines
On May 29, 2026, President Trump signed an executive order titled “Realigning United States Core Childhood Vaccine Recommendations With Best Practices from Peer, Developed Countries” endorsing a scientific assessment done earlier this year by the U.S. Department of Health and Human Services (DHHS) calling for a reduction in the number of recommended vaccines for children […]
Ebola Outbreak Pushing Development of Vaccines for Bundibugyo Strain
The current outbreak of Ebola virus disease in the Democratic Republic of the Congo (DRC) and Uganda which began only a couple of weeks ago is already reportedly the third largest in history and, according to the World Health Organization’s (WHO) Director-General Tedros Adhanom Ghebreyesus, “spreading rapidly,” with more than 900 suspected cases of the […]
“Vocal Supporter” of Vaccines Nominated to Be CDC Director
On Apr. 17, 2026, the Trump administration nominated retired Coast Guard rear admiral and former deputy surgeon general Erica Schwartz, MD, JD, MPH to be the next director of the U.S. Centers for Disease Control and Prevention (CDC). If confirmed by the U.S. Senate, Dr. Schwartz would succeed Jay Bhattacharya, MD, PhD who has been […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]
Upcoming ACIP Meeting to Focus on COVID-19 Shot Injuries
The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) are scheduled to meet on Mar. 18-19, 2026 to discuss the injuries to people who received COVID-19 shots and the matter of safety monitoring related to the shots, particularly with regard to the development of myocarditis (inflammation of the heart […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]